The NRAS mutation is found in several cancers such as melanoma (13 ~ 25%), colorectal cancer (1 ~ 6%), lung cancer (1%), thyroid cancer (7%) and hepatocellular carcinoma (10%). It is known that the response to colorectal cancer drug such as Erbitux and Cetuximab decreased and the prognosis of the patient with metastatic colorectal cancer is poor if the patient has NRAS mutation.
PNAClamp™ Mutation Detection Kit NRAS
For detection of NRAS mutations in tissue biopsies
Cat. No. PNAC-1101
Other products
Molecular diagnostic kit (qPCR) for Streptococcus agalactiae detection – PF0001
Kit for molecular detection (qPCR) of Streptococcus agalactiae with Taqman...
CannaSEX qPCR
Kit for the determination of the sexual dimorphism of Cannabis...
CALCIUM CHLORIDE
Calcium chloride is a common reagent in biochemistry and molecular...
PNAClamp™ Mutation Detection Kit EGFR (ver.2)
For detection of EGFR mutations in tissue biopsies - Lung...